| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1028003925 |
| P356 | DOI | 10.1186/1476-4598-9-254 |
| P932 | PMC publication ID | 2955615 |
| P698 | PubMed publication ID | 20860785 |
| P5875 | ResearchGate publication ID | 46402829 |
| P50 | author | Thorsten Stiewe | Q56528724 |
| Albert Sickmann | Q28211405 | ||
| P2093 | author name string | Stephanie M Pütz | |
| Fotini Vogiatzi | |||
| P2860 | cites work | Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells. | Q35076272 |
| Heat shock protein 90 as a molecular target for cancer therapeutics | Q35099516 | ||
| Polyoma and SV40 proteins differentially regulate PP2A to activate distinct cellular signaling pathways involved in growth control | Q35539933 | ||
| The urokinase plasminogen activator system: role in malignancy | Q35644332 | ||
| The undecided serpin. The ins and outs of plasminogen activator inhibitor type 2. | Q36263571 | ||
| Protein detection methods in proteomics research | Q36285054 | ||
| Redox regulation of precursor cell function: insights and paradoxes | Q36342622 | ||
| Telomerase extends the lifespan of virus-transformed human cells without net telomere lengthening | Q36449812 | ||
| Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer | Q36465265 | ||
| Two-dimensional electrophoresis of membrane proteins. | Q36902896 | ||
| p73 poses a barrier to malignant transformation by limiting anchorage-independent growth | Q38294005 | ||
| Regulation of tumor cell mitochondrial homeostasis by an organelle-specific Hsp90 chaperone network. | Q40063505 | ||
| Biological and clinical aspects of plasminogen activator inhibitor type 2. | Q40378014 | ||
| Proteomic analysis of selected prognostic factors of breast cancer. | Q40527843 | ||
| A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells | Q40572608 | ||
| Immortalization and transformation of primary human airway epithelial cells by gene transfer. | Q40722115 | ||
| Critical role for SV40 small-t antigen in human cell transformation | Q40746221 | ||
| Formation of intracranial tumors by genetically modified human astrocytes defines four pathways critical in the development of human anaplastic astrocytoma | Q46338106 | ||
| Multiple stages of malignant transformation of human endothelial cells modelled by co-expression of telomerase reverse transcriptase, SV40 T antigen and oncogenic N-ras. | Q52118219 | ||
| Mass cultured human fibroblasts overexpressing hTERT encounter a growth crisis following an extended period of proliferation. | Q52165691 | ||
| A genetically tractable model of human glioma formation. | Q52542891 | ||
| Ruthenium (II) tris-bathophenanthroline disulfonate is well suitable for Tris-Glycine PAGE but not for Bis-Tris gels | Q55884760 | ||
| The tumor-suppressive functions of the human INK4A locus | Q57187959 | ||
| A simple assay for quantification of protein in tissue sections, cell cultures, and cell homogenates, and of protein immobilized on solid surfaces | Q73094316 | ||
| Immunohistochemical detection of uroplakin III, cytokeratin 7, and cytokeratin 20 in canine urothelial tumors | Q73103242 | ||
| Opinion: Comparative biology of mouse versus human cells: modelling human cancer in mice | Q75312804 | ||
| Current two-dimensional electrophoresis technology for proteomics | Q22252855 | ||
| Proteomic analysis of p16ink4a-binding proteins | Q24298437 | ||
| Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a | Q24324559 | ||
| Extension of life-span by introduction of telomerase into normal human cells | Q24336088 | ||
| High resolution two-dimensional electrophoresis of proteins | Q24608190 | ||
| Cluster analysis and display of genome-wide expression patterns | Q24644463 | ||
| A new member of the hsp90 family of molecular chaperones interacts with the retinoblastoma protein during mitosis and after heat shock | Q24648784 | ||
| Inhibition of retinoblastoma protein degradation by interaction with the serpin plasminogen activator inhibitor 2 via a novel consensus motif | Q24682801 | ||
| Specific Association of Human Telomerase Activity with Immortal Cells and Cancer | Q27860801 | ||
| Creation of human tumour cells with defined genetic elements | Q28141602 | ||
| Protein mapping by combined isoelectric focusing and electrophoresis of mouse tissues. A novel approach to testing for induced point mutations in mammals | Q28143353 | ||
| A comparison between Sypro Ruby and ruthenium II tris (bathophenanthroline disulfonate) as fluorescent stains for protein detection in gels | Q28202225 | ||
| Improved Ruthenium II tris (bathophenantroline disulfonate) staining and destaining protocol for a better signal-to-background ratio and improved baseline resolution | Q28248103 | ||
| Peroxiredoxin 6, a 1-Cys peroxiredoxin, functions in antioxidant defense and lung phospholipid metabolism | Q28250381 | ||
| SV40 large T antigen targets multiple cellular pathways to elicit cellular transformation | Q28282761 | ||
| Annexin 2 binding to phosphatidylinositol 4,5-bisphosphate on endocytic vesicles is regulated by the stress response pathway | Q28583310 | ||
| Towards a high resolution separation of human cerebrospinal fluid. | Q30708834 | ||
| About the mechanism of interference of silver staining with peptide mass spectrometry. | Q33200410 | ||
| Proteomics-based approach identifying autoantibody against peroxiredoxin VI as a novel serum marker in esophageal squamous cell carcinoma | Q33262742 | ||
| Protein profiling by the combination of two independent mass spectrometry techniques. | Q33280961 | ||
| Silver- and Coomassie-staining protocols: detection limits and compatibility with ESI MS. | Q33285278 | ||
| Proteomics analysis of H-RAS-mediated oncogenic transformation in a genetically defined human ovarian cancer model | Q33947451 | ||
| Enumeration of the simian virus 40 early region elements necessary for human cell transformation | Q34117528 | ||
| The interaction of SV40 small tumor antigen with protein phosphatase 2A stimulates the map kinase pathway and induces cell proliferation. | Q34345750 | ||
| Cancer modeling in the modern era: progress and challenges | Q34520417 | ||
| P304 | page(s) | 254 | |
| P577 | publication date | 2010-09-22 | |
| P1433 | published in | Molecular Cancer | Q15724585 |
| P1476 | title | Malignant transformation in a defined genetic background: proteome changes displayed by 2D-PAGE | |
| P478 | volume | 9 |
| Q36798968 | Majority of differentially expressed genes are down-regulated during malignant transformation in a four-stage model |
| Q39357652 | Proteomic investigation of anti‐tumor activities exerted by sinularin against A2058 melanoma cells |
| Q37979012 | TRAP1 regulation of mitochondrial life or death decision in cancer cells and mitochondria-targeted TRAP1 inhibitors |
Search more.